Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000728741 | SCV000856350 | likely benign | not specified | 2017-09-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001675962 | SCV001895274 | benign | not provided | 2020-08-05 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000728741 | SCV002066394 | benign | not specified | 2017-07-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002352240 | SCV002650054 | uncertain significance | Inborn genetic diseases | 2015-10-12 | criteria provided, single submitter | clinical testing | This variant, c.594-4dupT variant is located in intron 7 of the RPS6KA3 gene. This results in the insertion of an extra T residue between the 3rd and 4th nucleotides before exon 8. This variant was not reported in population-based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP) and 1000 Genomes Project. Using the BDGP and ESEfinder splice site prediction tools, this alteration does not have any significant effect on this acceptor splice site; however, direct evidence is unavailable. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear. |
Labcorp Genetics |
RCV002535090 | SCV003256859 | benign | Coffin-Lowry syndrome; Intellectual disability, X-linked 19 | 2024-12-24 | criteria provided, single submitter | clinical testing |